Syngen Biotechsp. z o.o.
Retail sale of medical and orthopaedic goods in specialised stores
Overview
Syngen Biotech is a company specializing in equipping laboratories with high-quality scientific research equipment and providing diagnostic tests and reagents for molecular biology to diagnostic and research centers across Poland. They are the exclusive distributor in Poland for various brands, including Molecular Devices and Azure Biosystems, and have developed their own brand of reagents for DNA and RNA isolation and PCR reactions. Additionally, they offer technical support and consulting services.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2000-02-23. Active
29 1750 1064 0000 0000 0107 1197- 61 1750 1064 0000 0000 0107 1203
- 73 1750 1064 0000 0000 0107 1181
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
4 public aid cases recorded, with a total value of $9,063.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 17, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $833$833 | Marszałek Województwa Dolnośląskiego | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,494$2,494 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,020$3,020 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
128 tenders recorded as contractor: 86 national ($1,766,103) and 42 EU ($13,719,384).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 11, 2026 | DZP.242.246.2026. Sukcesywna dostawa odczynników, kontroli i materiałów zużywalnych dla Laboratoriów Analitycznych (3 obszary) z dzierżawą aparatów na 24 miesiące. | –– | Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wrocławiu | |
| Aug 3, 2026 | Dostawa odczynników laboratoryjnych | $249.4K$249,446 | Uniwersyteckie Centrum Kliniczne Im. Prof. K. Gibińskiego Śląskiego Uniwersytetu Medycznego w Katowicach | |
| Jul 29, 2026 | Postępowanie o udzielenie zamówienia publicznego prowadzone w trybie podstawowym bez negocjacji na dostawy odczynników | $399$399 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zakaźny w Warszawie |
Public sector contracts
Syngen Biotech is the contractor in 39 public sector contracts, worth PLN 2.70m in total. They were signed with 28 public buyers.
| Public buyer | Value | |
|---|---|---|
| Szkoła Główna Gospodarstwa Wiejskiego w Warszawie | PLN 3,424 | |
| Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie | PLN 26,523 | |
| Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie | PLN 82,171 | |
| Uniwersytecki Szpital Dziecięcy w Krakowie | PLN 28,386 | |
| Uniwersytet Szczeciński | PLN 1,085 |
Public procurement disputes (KIO)
Syngen Biotech has been a party to 1 case before the National Appeal Chamber (since 2011). It filed 1 appeal (1 rejected).
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Małgorzata Violetta Chrabańska Ziętek (61) | 990 | $13,371.15 | 99% |
Others | 10 | $135.06 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Solve Medicalsp. z o.o. | $9,171,826.22 | solvemedical.pl | ||
| SonolifeP.S.A. | $3,663,813.98 | sonolife.pl | ||
| Medical Marketsp. z o.o. | $3,352,570.35 | medical-market.pl | ||
| Spacemedsp. z o.o. | $3,209,118.83 | spacemed.pl | ||
| Alisiossp. z o.o. | $1,422,750.68 | alisios.pl | ||
| A-Biotechsp. z o.o. | $1,048,531.83 | a-biotech.pl | ||
| Bio-Labsp. z o.o. | $320,999.14 | bio-lab.com.pl | ||
| Medical Smart Integratorsp. z o.o. | $317,541.89 | medicalsmartintegrator.pl | ||
| Medinn Tecsp. z o.o. | $314,638.05 | medinntec.pl | ||
| Pergamonmedsp. z o.o. | $296,205.09 | pergamonmed.pl |
FAQ
Last updated: 2026-07-04